Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women

References

• World Health Organization. Global health observatory. Geneva: World Health Organization; 2018. Available from: who.int/gho/database/en/. Accessed June 21, 2018.
   Google Scholar
• Sung H , Ferlay J , Siegel RL , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2021;71(3):209–249. doi:10.3322/caac.21660 33538338
   PubMed Web of Science ®Google Scholar
• Engmann NJ , Golmakani MK , Miglioretti DL , et al. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol . 2017;3(9):1228–1236. doi:10.1001/jamaoncol.2016.6326 28152151
   PubMed Web of Science ®Google Scholar
• Pettersson A , Graff RE , Ursin G , et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst . 2014;106(5):dju078. doi:10.1093/jnci/dju078 24816206
   PubMedGoogle Scholar
• Sung H , Ren J , Li J , et al. Breast cancer risk factors and mammographic density among high-risk women in urban China. NPJ Breast Cancer . 2018;4:3. doi:10.1038/s41523-018-0055-9 29423438
   PubMed Web of Science ®Google Scholar
• Shieh Y , Scott CG , Jensen MR , et al. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res . 2019;21(1):48. doi:10.1186/s13058-019-1129-9 30944014
   PubMed Web of Science ®Google Scholar
• Dibaba DT , Ogunsina K , Braithwaite D , et al. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype. Breast Cancer Res Treat . 2019;174(1):209–218. doi:10.1007/s10549-018-5056-8 30465158
   PubMed Web of Science ®Google Scholar
• Gu L , Cao C , Fu J , et al. Serum adiponectin in breast cancer: a meta-analysis. Medicine (Baltimore) . 2018;97(29):e11433. doi:10.1097/MD.0000000000011433 30024516
   PubMed Web of Science ®Google Scholar
• Macis D , Aristarco V , Johansson H , et al. A novel automated immunoassay platform to evaluate the association of adiponectin and leptin levels with breast cancer risk. Cancers (Basel) . 2021;13(13):3303. doi:10.3390/cancers13133303 34209441
   PubMed Web of Science ®Google Scholar
• Mallik R , Chowdhury TA . Metformin in cancer. Diabetes Res Clin Pract . 2018;143:409–419. doi:10.1016/j.diabres.2018.05.023 29807101
   PubMed Web of Science ®Google Scholar
• Garvey WT , Mechanick JI , Brett EM , et al. American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. EndocrPract . 2016;22(Suppl 3):1–203. doi:10.4158/EP161365.GL
   Web of Science ®Google Scholar
• Cao W , Chen HD , Yu YW , et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl) . 2021;134(7):783–791. doi:10.1097/CM9.0000000000001474 33734139
   PubMed Web of Science ®Google Scholar
• Simone V , D’Avenia M , Argentiero A , et al. Obesity and breast cancer: molecular interconnections and potential clinical applications. Oncologist . 2016;21(4):404–417. doi:10.1634/theoncologist.2015-0351 26865587
   PubMed Web of Science ®Google Scholar
• Donohoe CL , Lysaght J , O’Sullivan J , et al. Emerging concepts linking obesity with the hallmarks of cancer. Trends Endocrinol Metab . 2017;28(1):46–62. doi:10.1016/j.tem.2016.08.004 27633129
   PubMed Web of Science ®Google Scholar
• Atakpa EC , Brentnall AR , Astley S , et al. The relationship between body mass index and mammographic density during a premenopausal weight loss intervention. Study Cancers (Basel) . 2021;13(13):3245. doi:10.3390/cancers13133245 34209579
   PubMed Web of Science ®Google Scholar
• Dai H , Yan Y , Wang P , et al. Distribution of mammographic density and its influential factors among Chinese women. Int J Epidemiol . 2014;43(4):1240–1251. doi:10.1093/ije/dyu042 24639441
   PubMed Web of Science ®Google Scholar
• Yap YS , Lu YS , Tamura K , et al. Insights into breast cancer in the east vs the west: a review. JAMA Oncol . 2019;5(10):1489–1496. doi:10.1001/jamaoncol.2019.0620 31095268
   PubMed Web of Science ®Google Scholar
• De A , Kuppusamy G . Metformin in breast cancer: preclinical and clinical evidence. CurrProbl Cancer . 2020;44(1):100488. doi:10.1016/j.currproblcancer.2019.06.003
   PubMed Web of Science ®Google Scholar
• Rennert G , Rennert HS , Gronich N , et al. Use of metformin and risk of breast and colorectal cancer. Diabetes Res Clin Pract . 2020;165:108232. doi:10.1016/j.diabres.2020.108232 32446797
   PubMed Web of Science ®Google Scholar
• Samuel SM , Varghese E , Koklesová L , et al. Counteracting chemoresistance with metformin in breast cancers: targeting cancer stem. Cells Cancers (Basel) . 2020;12(9):2482. doi:10.3390/cancers12092482
   Web of Science ®Google Scholar
• Sharma P , Kumar S . Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD). Cell Oncol (Dordr) . 2018;41(6):637–650. doi:10.1007/s13402-018-0398-0 30088260
   PubMed Web of Science ®Google Scholar
• Jiralerspong S , Goodwin PJ . Obesity and breast cancer prognosis: evidence, challenges, and opportunities. J Clin Oncol . 2016;34(35):4203–4216. doi:10.1200/JCO.2016.68.4480 27903149
   PubMed Web of Science ®Google Scholar
• Incio J , Ligibel JA , McManus DT , et al. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2. Sci Transl Med . 2018;10(432):eaag0945. doi:10.1126/scitranslmed.aag0945 29540614
   PubMed Web of Science ®Google Scholar
• Goodwin PJ , Pritchard KI , Ennis M , et al. Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer . 2008;8(6):501–505. doi:10.3816/CBC.2008.n.060 19073504
   PubMed Web of Science ®Google Scholar
• Gronich N , Rennert G . Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol . 2013;10(11):625–642. doi:10.1038/nrclinonc.2013.169 24080598
   PubMed Web of Science ®Google Scholar
• Lee CI , Chen LE , Elmore JG . Risk-based breast cancer screening: implications of breast density. Med Clin North Am . 2017;101(4):725–741. doi:10.1016/j.mcna.2017.03.005 28577623
   PubMed Web of Science ®Google Scholar
• D’Orsi CJ , Sickles EA , Mendelson EB , et al. American College of Radiology Breast Imaging Reporting and Data System BI-RADS . 5th ed. Reston, VA: American Colege of Radiology; 2013.
   Google Scholar
• Boyd NF , Martin LJ , Yaffe MJ , et al. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res . 2011;13(6):223. doi:10.1186/bcr2942 22114898
   PubMed Web of Science ®Google Scholar
• Boyd NF , Guo H , Martin LJ , et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med . 2007;356(3):227–236. doi:10.1056/NEJMoa062790 17229950
   PubMed Web of Science ®Google Scholar
• Lee Argov EJ , Acheampong T , Terry MB , et al. Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density. Breast Cancer Res . 2020;22(1):99. doi:10.1186/s13058-020-01336-0 32933550
   PubMed Web of Science ®Google Scholar
• Bershteĭn LM , Vasil’ev DA , Kovalenko IG , et al. The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women. VoprOnkol . 2012;58(1):45–49.
   Google Scholar
• Ozturk MA , Ozturk S , Eryilmaz M , et al. Does metformin affect mammographic breast density in postmenopausal women with type 2 diabetes. Gynecol Endocrinol . 2020;36(9):800–802. doi:10.1080/09513590.2020.1725972 32037910
   PubMed Web of Science ®Google Scholar
• Oskar S , Engmann NJ , Azus AR , et al. Gestational diabetes, type II diabetes, and mammographic breast density in a U.S. racially diverse population screened for breast cancer. Cancer Causes Control . 2018;29(8):731–736. doi:10.1007/s10552-018-1048-6 29948515
   PubMed Web of Science ®Google Scholar
• Amadou A , Ferrari P , Muwonge R , et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev . 2013;14(8):665–678. doi:10.1111/obr.12028 23615120
   PubMed Web of Science ®Google Scholar
• Roberts CK , Hevener AL , Barnard RJ . Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol . 2013;3(1):1–58. doi:10.1002/cphy.c110062 23720280
   PubMed Web of Science ®Google Scholar
• Larsson SC , Mantzoros CS , Wolk A . Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer . 2007;121(4):856–862. doi:10.1002/ijc.22717 17397032
   PubMed Web of Science ®Google Scholar
• García-Estévez L , Cortés J , Pérez S , et al. Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Front Oncol . 2021;11:705911. doi:10.3389/fonc.2021.705911 34485137
   PubMed Web of Science ®Google Scholar
• Jung SY , Mancuso N , Papp J , et al. Post genome-wide gene-environment interaction study: the effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization. PLoS One . 2019;14(6):e0218917. doi:10.1371/journal.pone.0218917 31246991
   PubMed Web of Science ®Google Scholar
• Eliassen AH , Tworoger SS , Mantzoros CS , et al. Circulating insulin and C-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev . 2007;16(1):161–164. doi:10.1158/1055-9965.EPI-06-0693 17220346
   PubMed Web of Science ®Google Scholar
• Kachhawa P , Kachhawa K , Agrawal D , et al. Association of dyslipidemia, increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer in urban areas of North and Central India. J Midlife Health . 2018;9(2):85–91. doi:10.4103/jmh.JMH_77_17 29962807
   PubMedGoogle Scholar
• Parida S , Siddharth S , Sharma D . Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci . 2019;20(10):2519. doi:10.3390/ijms20102519
   PubMed Web of Science ®Google Scholar
• Cha YJ , Koo JS . Adipokines as therapeutic targets in breast cancer treatment. Expert OpinTher Targets . 2018;22(11):941–953. doi:10.1080/14728222.2018.1538356
   PubMed Web of Science ®Google Scholar
• Iyengar NM , Zhou XK , Gucalp A , et al. Systemic correlates of white adipose tissue inflammation in early-stage breast cancer. Clin Cancer Res . 2016;22(9):2283–2289. doi:10.1158/1078-0432.CCR-15-2239 26712688
   PubMed Web of Science ®Google Scholar
• Lira LG , Justa RM , Carioca AAF , et al. Plasma and erythrocyte ω-3 and ω-6 fatty acids are associated with multiple inflammatory and oxidative stress biomarkers in breast cancer. Nutrition . 2019;58:194–200. doi:10.1016/j.nut.2018.07.115 30553106
   PubMed Web of Science ®Google Scholar
• Vega S , Basurto L , Saucedo R , et al. Similar to adiponectin, serum levels of osteocalcin are associated with mammographic breast density in postmenopausal women. J ObstetGynaecol Can . 2018;40(2):186–192. doi:10.1016/j.jogc.2017.06.036
   Web of Science ®Google Scholar
• Dossus L , Rinaldi S , Biessy C , et al. Circulating leptin and adiponectin, and breast density in premenopausal Mexican women: the Mexican Teachers’ Cohort. Cancer Causes Control . 2017;28(9):939–946. doi:10.1007/s10552-017-0917-8 28677026
   PubMed Web of Science ®Google Scholar
• Pham DV , Raut PK , Pandit M , et al. Globular adiponectin inhibits breast cancer cell growth through modulation of inflammasome activation: critical role of sestrin2 and AMPK signaling. Cancers (Basel) . 2020;12(3):613. doi:10.3390/cancers12030613
   Web of Science ®Google Scholar
• Katira A , Tan PH . Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity. Expert OpinTher Targets . 2015;19(8):1105–1125. doi:10.1517/14728222.2015.1035710
   Web of Science ®Google Scholar
• Khan S , Shukla S , Sinha S , et al. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev . 2013;24(6):503–513. doi:10.1016/j.cytogfr.2013.10.001 24210902
   PubMed Web of Science ®Google Scholar
• Vona-Davis L , Howard-McNatt M , Rose DP . Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev . 2007;8(5):395–408. doi:10.1111/j.1467-789X.2007.00396.x 17716297
   PubMed Web of Science ®Google Scholar
• Lei X , Wu Q , Leng W , et al. Exenatide reduces cardiomyocyte apoptosis by stimulating adiponectin secretion and activating APPL1-AMPK-PPARα axis. Ann Transl Med . 2019;7(14):326. doi:10.21037/atm.2019.06.17 31475196
   PubMed Web of Science ®Google Scholar